Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) inhibits insulin signal transduction in a variety of cell backgrounds, which might contribute to peripheral insulin resistance. However, because of the large number of potential phosphorylation sites, the mechanism of inhibition has been difficult to determine. One serine residue located near the phosphotyrosine-binding (PTB) domain in IRS-1 (Ser(307) in rat IRS-1 or Ser(312) in human IRS-1) is phosphorylated via several mechanisms, including insulin-stimulated kinases or stress-activated kinases like JNK1. During a yeast tri-hybrid assay, phosphorylation of Ser(307) by JNK1 disrupted the interaction between the catalytic domain of the insulin receptor and the PTB domain of IRS-1. In 32D myeloid progenitor cells, phosphorylation of Ser(307) inhibited insulin stimulation of the phosphatidylinositol 3-kinase and MAPK cascades. These results suggest that inhibition of PTB domain function in IRS-1 by phosphorylation of Ser(307) (Ser(312) in human IRS-1) might be a general mechanism to regulate insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, phosphorylation of these serine residues impedes the normal association of IRS-1 with the insulin receptor, thereby impairing downstream propagation of insulin signaling (16,19).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationKuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Research works printed but not linked: 6
- Maezono, K., Osman, A., Patti, M. E., Cusi, K., Pendergrass, M., DeFronzo, R. A., and Mandarino, L. (1998) Diabetes 47, 333A (abstr.)
- Carboni, J. M., Yan, N., Cox, A. D., Bustelo, X., Graham, S. M., Lynch, M. J., Weinmann, R., Seizinger, B. R., Der, C. J., Barbacid, M., and Manne, V. (1995) Oncogene 10, 1905-1913
- Myers, M. G., Jr., Wang, L. M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H., and White, M. F. (1994) Mol. Cell. Biol. 14, 3577-3587
- Delahaye, L., Mothe-Satney, I., Myers, M. G., Jr., White, M. F., and Van Obberghen, E. (1998) Endocrinology 139, 4911-4919 · DOI · Paper page
- O'Neill, T. J., Craparo, A., and Gustafson, T. A. (1994) Mol. Cell. Biol. 14, 6433-6442
- Chin, J. E., Liu, F., and Roth, R. A. (1994) Mol. Endocrinol. 8, 51-58
Cited by
Items 401–500 of 999
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
Chun, K., Choi, K., Lee, D.-H., Jung, Y., Henry, R. R., Ciaraldi, T. P., & Kim, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00538.2010 · Cited by 57
“In the insulin-signaling pathway, tyrosine phosphorylation of IRS-1 is a key step because it permits this docking protein to interact with signaling proteins that promote insulin action (2).”
BackgroundYammani, R. R., & Loeser, R. F. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3705 · Cited by 53
“Increased phosphorylation of IRS-1 at this serine residue has been reported to inhibit IRS-1 tyrosine (serine-612) phosphorylation, resulting in inhibition of downstream phosphorylation of AKT [26,27].”
BackgroundHu, Y., Hou, Z., Liu, D., & Yang, X. (2016) · Food & Function · doi:10.1039/c5fo01467k · Cited by 52
Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis
Chen, Y., Huang, L., Dong, Y., Tao, C., Zhang, R., Shao, H., & Shen, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.573599 · Cited by 65
Shen, Q., Cline, G. W., Shulman, G. I., Leibowitz, M. D., & Davies, P. J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311729200 · Cited by 53
Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity
Fujii, N., Boppart, M. D., Dufresne, S. D., Crowley, P. F., Jozsi, A. C., Sakamoto, K., Yu, H., Aschenbach, W. G., Kim, S., Miyazaki, H., et al. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00415.2003 · Cited by 53
“Therefore, the possible role of IRS-2 in the inhibition of ERK and Akt signaling remains to be examined.”
BackgroundInfluentialSelf-citationModulation of the action of insulin by angiotensin-(1–7)
Dominici, F. P., Burghi, V., Muñoz, M. C., & Giani, J. F. (2014) · Clinical Science · doi:10.1042/cs20130333 · Cited by 52
Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway
Wei, Y., Gao, J., Qin, L., Xu, Y., Dongchao, W., Shi, H., Xu, T., & Liu, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.040 · Cited by 53
Brummer, T., Schmitz‐Peiffer, C., & Daly, R. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07865.x · Cited by 74
Talukdar, I., Szeszel-Fedorowicz, W., & Salati, L. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505531200 · Cited by 53
PPARs and their Effects on the Cardiovascular System
Oyekan, A. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531845 · Cited by 61
“[36] Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF.”
BackgroundFunctional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer
Avivar‐Valderas, A., McEwen, R. K., Taheri‐Ghahfarokhi, A., Carnevalli, L. S., Hardaker, E. L., Maresca, M., Hudson, K., Harrington, E. A., & Cruzalegui, F. H. (2018) · Oncotarget · doi:10.18632/oncotarget.25118 · Cited by 50
“It has been reported that MAP3K1 downstream target, JNK, mediates IRS1 degradation via phosphorylation [22-24, 30].”
BackgroundYe, P., Liu, J., Xu, W., Liu, D., Ding, X., Le, S., Zhang, H., Chen, S., Chen, M., & Xia, J. (2018) · Hepatology · doi:10.1002/hep.30485 · Cited by 53
“(37) Besides, under induction factors such as lipid peroxidation in the steatotic liver, JNK would be activated to increase the transcription of proinflammatory cytokines through activator protein-1.(38) Hepatic gluconeogenesis also depended on the p38 pathway.”
BackgroundXu, J. H., Kim, H. T., Ma, Y., Ling, Z., Zhai, L., Kokorina, N. A., Wang, P., & Messina, J. L. (2008) · Endocrinology · doi:10.1210/en.2007-0922 · Cited by 54
Güney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 60
“phorylation has been implicated in insulin resistance [141].”
BackgroundMcCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.020 · Cited by 53
“[2–5], and fat-mediated activation of JNK, leading to phosphorylation of S307 in IRS-1, is now believed to be a key mediator of fat-induced insulin resistance in skeletal muscle [6–11].”
BackgroundImmunomodulatory role of prolactin in diabetes development
Čejková, P., Fojtíková, M., & Cerna, M. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.031 · Cited by 51
“The primary mechanism through which inflammatory signaling leads to insulin resistance is the inhibition of signaling downstream of the insulin receptor, as shown in case of TNF-α and its inhibitory phospohorylation of IRS-1 with subsequent disability of IRS-1 to associate with insulin receptor and thereby inhibition…”
BackgroundNishiumi, S., Yoshida, M., Azuma, T., Yoshida, K., & Ashida, H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq052 · Cited by 52
“, 1997), resulting in disorders of the insulin signaling pathway in adipocytes (Aguirre et al., 2002).”
BackgroundLiver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 54
Street, M. E., Viani, I., Ziveri, M. A., Volta, C., Smerieri, A., & Bernasconi, S. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0752 · Cited by 50
Wang, D., & Mitchell, E. S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160159 · Cited by 49
“Serine 307 phosphorylation of IRS-1 attenuates insulin signaling, including Akt phosphorylation [15].”
BackgroundCai, C., Qian, L., Jiang, S., Sun, Y., Wang, Q., Ma, D., Xiao, G., Li, B., Xie, S., Gao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16822 · Cited by 49
Nagira, K., Sasaoka, T., Wada, T., Fukui, K., Ikubo, M., Hori, S., Tsuneki, H., Saito, S., & Kobayashi, M. (2005) · Endocrinology · doi:10.1210/en.2005-0825 · Cited by 50
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 55
“tion following JNK1 (Jun-N-terminal Kinase-1) activation (65,69,70).”
InfluentialWu, N., Lu, Y., He, B., Zhang, Y., Lin, J., Zhao, S., Zhang, W., Li, Y., & Han, P. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.08.020 · Cited by 52
Huang, W., Bansode, R. R., Bal, N. C., Mehta, M., & Mehta, K. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m019687 · Cited by 48
Endo, H., Hosono, K., Fujisawa, T., Takahashi, H., Sugiyama, M., Yoneda, K., Nozaki, Y., Fujita, K., Yoneda, M., Inamori, M., et al. (2009) · Gut · doi:10.1136/gut.2009.183624 · Cited by 49
“Indeed, a large number of protein kinases have been shown to cause the phosphorylation of IRS-1, including JNK,”
BackgroundCat, A. N. D., Callera, G. E., Friederich‐Persson, M., Sánchez, A., Dulak-Lis, M. G., Tsiropoulou, S., Montezano, A. C. I., He, Y., Briones, A. M., Jaisser, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21087-5 · Cited by 51
Nishikawa, T., & Araki, E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-19 · Cited by 53
Glutamate excitotoxicity attenuates insulin-like growth factor-i prosurvival signaling
Garcia-Galloway, E., Arango, C., Pons, S., & Torres‐Alemán, I. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.08.005 · Cited by 54
NOD1 activation induces innate immune responses and insulin resistance in human adipocytes
Zhou, Y.-J., Zhou, H., Li, Y., & Song, Y.-L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.08.001 · Cited by 51
Chai, B., Li, J.-Y., Zhang, W., Wang, H., & Mulholland, M. W. (2009) · Peptides · doi:10.1016/j.peptides.2009.03.006 · Cited by 47
“In this manner, insulin-activated JNK may act as a negative feedback regulator for insulin signaling[3,23].”
BackgroundMitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection
Hino, K., Nishina, S., Sasaki, K., & Hara, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.044 · Cited by 50
Alves, A. P. N. R., Fernandes, J. C., Fenerich, B. A., Coelho‐Silva, J. L., Scheucher, P. S., Simões, B. P., Rego, E. M., Ridley, A. J., Machado‐Neto, J. A., & Traina, F. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.030 · Cited by 47
Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40
Zhang, L., Chen, Z., Wang, Y., Tweardy, D. J., & Mitch, W. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2019 · Cited by 49
“What causes low levels of IRS1? Cell-based mechanisms have been proposed including phosphotyrosine-dephosphorylation, serine-threonine phosphorylation, and, ultimately, IRS1 degradation (1, 36, 38).”
BackgroundPsoriatic Arthritis and Diabetes Mellitus: A Narrative Review
Bello, G. D., Gisondi, P., Idolazzi, L., & Girolomoni, G. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00206-7 · Cited by 50
Attia, H., Albuhayri, S., Alaraidh, S., Alotaibi, A., Yacoub, H. I., Mohamad, R. A., & Alamin, M. A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22519 · Cited by 50
Zhang, B. B. (2002) · Frontiers in Bioscience · doi:10.2741/a820 · Cited by 47
Gupta, D., Varma, S., & Khandelwal, R. L. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21080 · Cited by 53
“Phosphorylation of IRS-1 at serine residue (312 in humans and 307 in rats) is an emerging prime target of TNFa-mediated impaired PI-3 kinase dependent signaling pathway [Aguirre et al., 2000, 2002; Sykiotis and Papavassiliou, 2001; Gao et al., 2002].”
BackgroundCarstensen, M., Wiza, C., Röhrig, K., Fahlbusch, P., Roden, M., Herder, C., & Ouwens, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085906 · Cited by 49
“This was associated with increased activation of the JNK signaling pathway, which inhibits insulin action via phosphorylation of Ser307 of insulin receptor substrate 1 [19,20].”
Al-Regaiey, K., Masternak, M. M., Bonkowski, M. S., Panici, J. A., Kopchick, J. J., & Bartke, A. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.1.18 · Cited by 50
“This kinase was reported to promote insulin resistance through the phosphorylation of insulin receptor substrate (IRS-1) at Ser307, which inhibits coupling of IRS-1 to the insulin receptor (29,30).”
BackgroundChapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 60
“, 2002), c-Jun N-terminus kinase ( JNK) (Aguirre et al., 2002; Lee et al., 2003b), mPLK (Kim et al.”
EGFR and FGFR Signaling through FRS2 Is Subject to Negative Feedback Control by ERK1/2
Wu, Y., Chen, Z., & Ullrich, A. (2003) · Biological Chemistry · doi:10.1515/bc.2003.134 · Cited by 46
“…as Gab1, Gab2 and IRS-1 has been shown to negatively or positively regulate the tyrosine phosphorylation state of the respective proteins (Paz et al., 1999; Roshan et al., 1999; Aguirre et al., 2000, 2002; Gual et al., 2001; Liu et al., 2001; Greene and Garofalo, 2002; Lynch and Daly, 2002).”
BackgroundKim, S. J., Roy, R. R., Kim, J. A., Zhong, H., Haddad, F., Baldwin, K. M., & Edgerton, V. R. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90668.2008 · Cited by 46
Jiang, S., Wang, Y., Ren, D., Li, J., Yuan, G., An, L., Du, P., & Ma, J. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.952838 · Cited by 47
“The activation of JNK has been shown to directly phosphorylate IRS1 at inhibitory sites that prevent recruitment of this protein to the activated insulin receptor (Aguirre et al., 2000, 2002).”
BackgroundTime now to TORC the TORC? New developments in m TOR pathway inhibition in lymphoid malignancies
Eyre, T. A., Collins, G. P., Goldstone, A. H., & Cwynarski, K. (2014) · British Journal of Haematology · doi:10.1111/bjh.12945 · Cited by 45
“When activated by loss of DEPTOR, S6K1 directly phosphorylates insulin receptor substrate 1 (IRS-1) resulting in its degradation (Aguirre et al, 2002).”
BackgroundMetabolic syndrome: is equine disease comparable to what we know in humans?
Ertelt, A., Barton, A. K., Schmitz, R. R., & Gehlen, H. (2014) · Endocrine Connections · doi:10.1530/ec-14-0038 · Cited by 55
Babaev, V. R., Yeung, M., Erbay, E., Ding, L., Zhang, Y., May, J. M., Fazio, S., Hotamışlıgil, G. S., & Linton, M. F. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307580 · Cited by 48
Hou, L., Yang, P., Jiang, F., Liu, Q. F., Wang, X., & Kang, L. (2017) · eLife · doi:10.7554/elife.22526 · Cited by 42
“The phosphorylated proteins usually display changed spatial structures, subcellular locations and catalytic activity, and thus play key roles in rapid cellular signaling (Aguirre et al., 2002; Ho et al., 2011; Hurley et al., 1990).”
BackgroundJIANG, G., DALLAS-YANG, Q., BISWAS, S., LI, Z., & ZHANG, B. B. (2004) · Biochemical Journal · doi:10.1042/bj20031207 · Cited by 45
Krisnamurti, D. G. B., Louisa, M., Poerwaningsih, E. H., Tarigan, T. J. E., Soetikno, V., Wibowo, H., & Nugroho, C. M. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1089298 · Cited by 54
“Phosphorylation of Ser307 in IRS1 limits insulin action by blocking connections with the insulin receptor (45).”
BackgroundZnT2 is a critical mediator of lysosomal-mediated cell death during early mammary gland involution
Hennigar, S. R., Seo, Y. A., Sharma, S., Soybel, D. I., & Kelleher, S. L. (2015) · Scientific Reports · doi:10.1038/srep08033 · Cited by 48
Beyer, T. A., & Werner, S. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5617 · Cited by 51
Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
Scazzocchio, B., Varí, R., D’Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., & Masella, R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800402-jlr200 · Cited by 231
“Conversely, the serine phosphorylation of IRS-1 (in particular at ser307 in mice) has been shown as a major player in the desensitization of insulin action (18, 25, 26) because it can interrupt IRS/IR interaction or promote IRS-1 pro-”
BackgroundC-Jun N-Terminal Kinase Mediates Tumor Necrosis Factor-α Suppression of Differentiation in Myoblasts
Strle, K., Broussard, S. R., McCusker, R. H., Shen, W.-H., LeCleir, J. M., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2006) · Endocrinology · doi:10.1210/en.2005-1541 · Cited by 44
Endoplasmic Reticulum Stress Impairs Insulin Signaling through Mitochondrial Damage in SH-SY5Y Cells
Koo, H.-J., Piao, Y., & Pak, Y. K. (2012) · Neurosignals · doi:10.1159/000333069 · Cited by 46
An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer
Mamay, C. L., Mingo-Sion, A. M., Wolf, D., Molina, M. D. C., & Berg, C. L. V. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206186 · Cited by 44
“Ser307 of IRS-1 has become particularly interesting since it lies adjacent to the protein tyrosine binding (PTB) domain, the region required for receptor binding (Aguirre et al., 2002).”
BackgroundEgawa, T., Tsuda, S., Ma, X., Hamada, T., & Hayashi, T. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2011 · Cited by 48
“and its phosphorylation has been demonstrated to inhibit insulin-stimulated tyrosine phosphorylation of IRS-1 and the subsequent activation of PI3K (4, 22).”
BackgroundShibata, M., Hakuno, F., Yamanaka, D., Okajima, H., Fukushima, T., Hasegawa, T., Ogata, T., Toyoshima, Y., Chida, K., Kimura, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126482 · Cited by 46
Mechanisms of Hemorrhage-Induced Hepatic Insulin Resistance: Role of Tumor Necrosis Factor-α
Ma, Y., Tóth, B. I., Keeton, A. B., Holland, L. T., Chaudry, I. H., & Messina, J. L. (2004) · Endocrinology · doi:10.1210/en.2004-0524 · Cited by 42
“Previous studies indicate that TNF promotes phosphorylation of IRS-1 at Ser307 by activating one or more MAPK signaling pathways (31, 44) and that Ser307 and Ser612 of IRS-1 can also be phosphorylated in response to activation of protein kinase C (32, 65).”
BackgroundRetractedLiu, F., Dallas-Yang, Q., Castriota, G. A., Fischer, P. A., Santini, F., Ferrer, M., Li, J., Akiyama, T. E., Berger, J. P., Zhang, B. B., et al. (2009) · Biochemical Journal · doi:10.1042/bj20082051 · Cited by 46
Waraich, R. S., Weigert, C., Kalbacher, H., Hennige, A. M., Lutz, S. Z., Häring, H., Schleicher, E. D., Voelter, W., & Lehmann, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708588200 · Cited by 50
Barbarroja, N., López-Pedrera, C., Garrido‐Sánchez, L., Mayas, M. D., Oliva‐Olivera, W., Bernal-López, M. R., Bekay, R. E., & Tinahones, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048155 · Cited by 46
“serine sites that negatively regulate normal signaling through the insulin receptor/IRS-1 axis and produce impaired insulin action [10,11,12].”
BackgroundRoy, P. K., Islam, J., & Lalhlenmawia, H. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00352-7 · Cited by 56
“TNFα plays an active role in insulin resistance because of its ability to bind IRS1 and IRS2 thereby phosphorylates serine residue and inhibits insulin stimulated tyrosine phosphorylation [84].”
BackgroundZhou, Q. G., Zhou, M., Lou, A., Xie, D., & Hou, F. F. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000322345 · Cited by 45
PI3K signaling in the pathogenesis of obesity: The cause and the cure
Beretta, M., Bauer, M. W., & Hirsch, E. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.11.004 · Cited by 48
Nemoto, S., Kobayashi, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00178.2011 · Cited by 40
Mao, Y., Hopkins, D. L., Zhang, Y., Li, P., Zhu, L., Dong, P., Liang, R., Dai, J., Wang, X., & Luo, X. (2016) · Meat Science · doi:10.1016/j.meatsci.2016.03.028 · Cited by 45
Diet, gut microbiota composition and feeding behavior
Kim, J. S., & de La Serre, C. B. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.026 · Cited by 41
“Cytokines, particularly TNF-α [27, 28] and Il-1β [29], can impair insulin signaling by phosphorylating insulin receptor substrate 1 (IRS1) at a serine (Ser307) site which prevents phosphorylation at the active tyrosine site.”
InfluentialWoo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 47
“TNF-α activates stress-response kinase pathways, including the IκB kinase β (IKKβ)/nuclear factor κ B (NFκB) and c-Jun N-terminal kinase (JNK) pathways, which promote insulin resistance via phosphorylation of IRS1 on serine residues [116], and by decreasing expression of GLUT-4 glucose transporters, which are crucial…”
BackgroundKim, J., & Lee, J. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040188.094 · Cited by 53
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 44
Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment
Bikman, B. T., Zheng, D., Reed, M. A., Hickner, R. C., Houmard, J. A., & Dohm, G. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00190.2009 · Cited by 41
Sadri, H., Bruckmaier, R. M., Rahmani, H. R., Ghorbani, G. R., Morel, I., & van Dorland, H. A. (2010) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2010.01005.x · Cited by 54
“Our study showed no changes in mRNA abundance of IRS1 over time; however, it has also been reported that serine phosphorylation of IRS1 can reduce its ability to bind to the INSR and initiate downstream signalling (Aguirre et al., 2002).”
PEDF-induced alteration of metabolism leading to insulin resistance
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.006 · Cited by 45
Is insulin signaling molecules misguided in diabetes for ubiquitin–proteasome mediated degradation?
Balasubramanyam, M., Rangasamy, S., & Mohan, V. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-1083-y · Cited by 48
“Proinflammatory cytokines have been shown to promote serine phosphorylation of IRS1 and IRS2 that inhibits coupling to the activated insulin receptor and/or p85 regulatory subunit of phosphatidylinositol-3 kinase [21, 22].”
BackgroundGirault, E. M., Alkemade, A., Foppen, E., Ackermans, M. T., Fliers, E., & Kalsbeek, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043244 · Cited by 43
“IRS1 serine phosphorylation at this site had been reported to decrease the affinity of IRS1 for the insulin receptor and increase IRS1 degradation [31], which seems sufficient to account for the glucocorticoid-induced decrease of insulin-stimulated glucose uptake in skeletal muscle [29].”
Wang, C., Liu, M., Riojas, R. A., Xin, X., Gao, Z., Zeng, R., Wu, J., Dong, L., & Liu, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806336200 · Cited by 44
Thirone, A. C. P., JeBailey, L., Bilan, P. J., & Klip, A. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1265 · Cited by 43
Li, L., Thompson, L. H., Zhao, L., & Messina, J. L. (2008) · Endocrinology · doi:10.1210/en.2008-0742 · Cited by 40
Bajaj, M., Medina-Navarro, R., Suraamornkul, S., Meyer, C., DeFronzo, R. A., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-0840 · Cited by 38
Metabolic reprogramming of macrophages in the context of type 2 diabetes
Witcoski, L., de Lima, J. D., Somensi, A. G., Santos, L. B. D. S., Paschoal, G. L., Uada, T. S., Bastos, T. S. B., de Paula, A. G. P., Luz, R. B. D. S., Czaikovski, A. P., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-02069-y · Cited by 48
“Phosphorylation sites of the JNK pathway include Ser312—in humans, and in mice, the site is called Ser307—as the primary site for protection by restriction of the phosphotyrosine-binding domain [1] and Ser302, which has also been shown to mediate the disruption of IRS-1 signaling.”
BackgroundArvisais, E. W., Hou, X., Wyatt, T. A., Shirasuna, K., Bollwein, H., Miyamoto, A., Hansen, T. R., Rueda, B. R., & Davis, J. S. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0312 · Cited by 42
Yang, L., Qian, Z., Ji, H., Yang, R., Wang, Y., Liang, X., Sheng, L., Zhao, B., & Zhang, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.061 · Cited by 40
“The inhibitory effect of free fatty acid on insulin signalingwas due to Ser phosphorylation of IRS-1 proteins, a major mechanism for suppression of IRS-1 function (Haruta et al., 2000; Aguirre et al., 2002).”
BackgroundPhosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Giraud, J., Haas, M., Feener, E. P., Copps, K. D., Dong, X., Dunn, S. L., & White, M. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0159 · Cited by 38
Self-citationComputational modelling of the regulation of Insulin signalling by oxidative stress
Smith, G. R., & Shanley, D. P. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-41 · Cited by 44
“In recent years it has expanded to include a more detailed description of Insulin-InR binding [28], integration with connected signalling pathways such as mTOR [29,30], EGF [31], MAPK [32] and whole-body insulin/glucose dynamics [33], though these aspects are not included in the model presented here.”
InfluentialGuo, R., Zheng, H., Li, Q., Qiu, X., Zhang, J., & Cheng, Z. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2021.100594 · Cited by 37
Bakar, M. H. A., Cheng, K., Sarmidi, M. R., Yaakob, H., & Huri, H. Z. (2015) · Molecules · doi:10.3390/molecules20058242 · Cited by 38
RetractedNovel link between inflammation and impaired glucose transport during equine insulin resistance
Waller, A. P., Huettner, L. E., Köhler, K., & Lacombe, V. A. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.07.003 · Cited by 37
Kiràly, M. A., Campbell, J. E., Park, E., Bates, H. E., Yue, J. T. Y., Rao, V., Matthews, S. G., Bikopoulos, G. J., Rozakis-Adcock, M., Giacca, A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90575.2008 · Cited by 42
Al‐Dwairi, A., Brown, A. R., Pabona, J. M. P., Van, T. H., Hamdan, H., Mercado, C. P., Quick, C. M., Wight, P. A., Simmen, R. C. M., & Simmen, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113058 · Cited by 39
“Notably, the enhanced liver IRS1 activation concomitant with increased blood glucose in ME1-Tg mice suggests the onset/ development of systemic insulin resistance [62].”
BackgroundYu, J.-S., Jin, J., & Li, Y. (2020) · STEMedicine · doi:10.37175/stemedicine.v1i4.49 · Cited by 38
“Besides, the probable existence of extra IKK phosphorylation sites on the IRS family proteins implies that they may represent a novel group of substrates for IKK kinases (89).”
BackgroundPelletier, A., Tardif, A., Gingras, M., Chiasson, J., & Coderre, L. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9303-7 · Cited by 37
“ERK1/2 has already been identified as a potent stimulator of IRS-1 serine phosphorylation [35] resulting in decreased IRS-1 tyrosine phosphorylation and thus, insulin action [66, 67].”
BackgroundPrada, P. O., Coêlho, M. S., Zecchin, H. G., Dolnikoff, M. S., Gasparetti, A. L., Furukawa, L. N. S., Saad, M. J. A., & Heimann, J. C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06028 · Cited by 36
“It has been reported that activation of JNK induces serine 307 phosphorylation of IRS-1 (Aguirre et al. 2002), leading to a decrease in the insulinstimulated PI3-K activity.”
BackgroundMethodInfluentialThe Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity
Johnston‐Cox, H., Eisenstein, A. S., Koupenova, M., Carroll, S. H., & Ravid, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098775 · Cited by 37
“This results in reduced insulin signaling and subsequent insulin resistance [11,13–21].”
BackgroundHigh‐fat Diet Alters PP2A, TC10, and CIP4 Expression in Visceral Adipose Tissue of Rats
Jun, H., Hwang, K., Kim, Y., & Park, T. (2008) · Obesity · doi:10.1038/oby.2008.220 · Cited by 37
Park, S. Y., Kim, M. H., Ahn, J. H., Lee, S. J., Lee, J. H., Eum, W. S., Choi, S. Y., & Kwon, H. Y. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.3.255 · Cited by 38
“The activation of PKCθ and JNK has been reported to induce serine phosphorylation of IRS-1 and inhibit an associated PI3K/Akt activity, thereby reducing the rate of glucose transport into the cells [3-5].”
InfluentialKovačević, S., Brkljačić, J. M., Milutinović, D. V., Gligorovska, L., Bursać, B. N., Elaković, I., & Djordjevic, A. D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.749328 · Cited by 45
“The mechanisms behind inflammation-related insulin signaling impairment include TNFα, which can the promote inhibitory phosphorylation of IRS1 on Ser 307 (100, 101) and whose concentration has been correlated with adipose tissue IRS1 inactivation in obese patients (102).”
BackgroundChae, C., Jung, S.-L., An, S.-H., Jung, C.-K., Nam, S.-N., & Kim, H.-T. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0068-9 · Cited by 40
Nagareddy, P. R., MacLeod, K. M., & McNeill, J. H. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq030 · Cited by 36
Metadata
- Authors
- Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1531-1537
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972590376
- Cited by
- 1,010
- References
- 55
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 30 · 2019: 43 · 2018: 41 · 2017: 33 · 2016: 40 · 2015: 36 · 2014: 57 · 2013: 45 · 2012: 58
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- IRS-1, insulin resistance, insulin signaling, phosphotyrosine binding domain, insulin receptor, JNK1, MAPK signaling, phosphatidylinositol 3-kinase, protein-protein interaction inhibition
- MeSH terms
- Animals, Anisomycin, Anti-Bacterial Agents, Cell Line, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, Phosphatidylinositol 3-Kinases, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.